Product Reviews

New Product Review: Levosert® intrauterine delivery system April 2015 (updated 12 February 2018)

12 March 2018

Levosert® is a levonorgestrel intrauterine system (LNG-IUS) newly launched in the UK for contraception and management of heavy menstrual bleeding. It contains 52mg levonorgestrel (identical to Mirena®) in a reservoir mounted on a T-shaped polyethylene frame. Initially launch in April 2015 licensed for 3 years, Levosert has now been approved in the UK for 4 years use (February 2018).

Please read this guidance document in conjunction with any relevant clinical statements for this topic.
These can be found by visiting the Clinical Statements section.

FSRH CEU New Product Review Kyleena® - January 2018

29 January 2018

The FSRH CEU has produced a new product review for Kyleena which summarises the key differences in the product and clinical characteristics between Kyleena and other LNG-IUS available in the UK.

This document is up-to-date

CEU New Product Review Jaydess Apr 2014

01 April 2014

Jaydess® is a levonorgestrel intrauterine system (LNG-IUS) newly launched in the UK for contraception. It is a smaller, lower dose version of the Mirena® LNG-IUS.

This document is up-to-date

CEU Product Review Eloine Daylette Nov 2015

01 November 2015

How effective is 20mcgEE/3mgDRSP as contraception? 20mcgEE/3mg DRSP is of comparable effectiveness to other combined oral contraceptives. [1,2,3] A large US observational study reports lower failure rates amongst users of a 24/4 EE/DRSP regimen than a 21/7 EE/DRSP regimen. The study also suggests greater contraceptive effectiveness of a 24/4 EE/DRSP regimen than with a 24/4 regimen containing EE in combination with norethisterone.

This document is up-to-date

CEU Statement/Review Estradiol/Nomegestrol Combined Pill, Zoely May 2013

01 May 2013

The combined oral contraceptive Zoely® (Merck, Sharp, and Dohme Limited) has been licensed in Europe since 2011 and will be available in the UK from May 2013. Zoely will be the second UK combined oral contraceptive (COC) to contain estradiol and to be formulated as an extended regimen since the introduction of Qlaira® (Bayer plc.)

This document is up-to-date

CEU New Product Review Caya Aug 2014

01 August 2014

Diaphragms are non-hormonal barrier methods of contraception that protect women against pregnancy by preventing sperm reaching the cervix. A single size contraceptive cap, FemCap, has been available since 2004, but until recently diaphragm products have been made in a range of sizes and designs. As a result women may have been required to try several types of diaphragm during the fitting process.

This document is up-to-date